Zevra Therapeutics, Inc. (ZVRA) stock
ZVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3060% below fair value
$9.40+0.15 (+1.62%)
Close on Nov 17, 2026Market cap $558.21MP/E 10.1Yield –
Zevra Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
Zevra Therapeutics's gross margin for the twelve months ending Jun 30, 2026 was 95.5%. For fiscal 2025 it was 84.5%, against 68.6% the year before. The highest annual figure on record is 97.8% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 84.5% | +15.9 |
| FY2024 | Dec 31, 2024 | 68.6% | −23.5 |
| FY2023 | Dec 31, 2023 | 92.1% | −5.7 |
| FY2022 | Dec 31, 2022 | 97.8% | +5.0 |
| FY2021 | Dec 31, 2021 | 92.8% | +70.7 |
| FY2019 | Dec 31, 2019 | 22.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 96.2% | +44.0 |
| Q1 FY2026 | Mar 31, 2026 | 94.8% | +1.4 |
| Q4 FY2025 | Dec 31, 2025 | 95.5% | +6.9 |
| Q3 FY2025 | Sep 30, 2025 | 95.2% | +57.6 |
| Q2 FY2025 | Jun 30, 2025 | 52.2% | +32.5 |
| Q1 FY2025 | Mar 31, 2025 | 93.4% | −1.5 |
| Q4 FY2024 | Dec 31, 2024 | 88.7% | −1.8 |
| Q3 FY2024 | Sep 30, 2024 | 37.7% | −57.4 |
| Q2 FY2024 | Jun 30, 2024 | 19.7% | −72.3 |
| Q1 FY2024 | Mar 31, 2024 | 94.9% | −1.2 |
| Q4 FY2023 | Dec 31, 2023 | 90.5% | −8.4 |
| Q3 FY2023 | Sep 30, 2023 | 95.0% | −0.1 |
| Q2 FY2023 | Jun 30, 2023 | 92.0% | −4.1 |
| Q1 FY2023 | Mar 31, 2023 | 96.1% | −3.7 |
| Q4 FY2022 | Dec 31, 2022 | 98.9% | +1.2 |
| Q3 FY2022 | Sep 30, 2022 | 95.1% | −4.9 |
| Q2 FY2022 | Jun 30, 2022 | 96.1% | +4.4 |
| Q1 FY2022 | Mar 31, 2022 | 99.8% | +653.9 |
| Q4 FY2021 | Dec 31, 2021 | 97.7% | +6.4 |
| Q3 FY2021 | Sep 30, 2021 | 100.0% | – |
| Q2 FY2021 | Jun 30, 2021 | 91.7% | – |
| Q4 FY2019 | Dec 31, 2019 | -554.1% | – |
| Q3 FY2019 | Sep 30, 2019 | 91.3% | – |
See a number that looks wrong?